Professor at University of Geneva, Switzerland, CEO of Therapeomic
Tudor Arvinte studied physics at University of Jassy, Romania, and received his Ph.D. in biophysics from University of Düsseldorf, Germany. He held numerous research positions in Europe and the USA at: Max-Planck Institute, Germany; C.N.R.S., France; Cornell University, New York; Texas A&M University; Ciba-Geigy U.K., Novartis, Switzerland. T. Arvinte worked with more than 200 biopharmaceuticals, three of his formulations reached the market, has over 90 publications and 15 patents.
He is Titular Professor at Geneva University and CEO of Therapeomic, Inc. Basel Switzerland, a contract research biotech company focused on the characterization and formulation of biopharmaceuticals.
Workshop: Achieve Stability, High Concentration, and Excellent Manufacturing Systems
- Discussing and assessing tools to tackle formulation challenges such as protein aggregates, protein characterization or particulate matter
- Diving into a real case study to understand the potential of mass spectrometry to acknowledge the characterization of biopharmaceutical higher order structure and conformational dynamics